Strategic Capital Advisers’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.91M Sell
7,609
-41
-0.5% -$20.6K 3.23% 7
2022
Q1
$3.9M Sell
7,650
-414
-5% -$200K 2.97% 9
2021
Q4
$4.05M Sell
8,064
-48
-0.6% -$21.7K 2.9% 11
2021
Q3
$3.17M Buy
8,112
+744
+10% +$308K 2.47% 17
2021
Q2
$2.95M Sell
7,368
-404
-5% -$161K 2.44% 18
2021
Q1
$2.89M Sell
7,772
-839
-10% -$291K 2.51% 14
2020
Q4
$3.02M Sell
8,611
-213
-2% -$71.4K 2.57% 15
2020
Q3
$2.75M Buy
8,824
+106
+1% +$32.6K 2.58% 15
2020
Q2
$2.57M Sell
8,718
-663
-7% -$190K 2.58% 15
2020
Q1
$2.34M Buy
9,381
+6,280
+203% +$1.73M 2.83% 14
2019
Q4
$912K Buy
3,101
+200
+7% +$52.3K 0.85% 36
2019
Q3
$630K Buy
2,901
+901
+45% +$217K 0.7% 37
2019
Q2
$488K Buy
+2,000
New +$481K 0.51% 41

Other funds holding UNH

Strategic Capital Advisers's UNH Position: Q2 2022 in Review

Strategic Capital Advisers reduced its UnitedHealth (UNH) stake by 0.54% in Q2 2022, selling an estimated $20.6K and leaving 7,609 shares worth $3.91M. The position accounts for 3.23% of the portfolio, ranked #7.

Strategic Capital Advisers first reported a position in UNH in Q2 2019 and has held it in 13 quarters since. The position peaked at $4.05M in Q4 2021. 2,959 funds tracked by Wall St. Rank hold UNH as of Q2 2022.

  • Strategic Capital Advisers held 7,609 shares of UnitedHealth worth $3.91M as of Q2 2022.
  • Strategic Capital Advisers sold 41 UnitedHealth shares in Q2 2022, an estimated $20.6K.
  • UnitedHealth made up 3.23% of Strategic Capital Advisers's portfolio in Q2 2022, its #7 holding.
  • Strategic Capital Advisers first reported a position in UnitedHealth in Q2 2019 and has held it in 13 quarters since.
  • Strategic Capital Advisers's UnitedHealth position peaked at $4.05M in Q4 2021.
  • 2,959 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2022.

Based on Strategic Capital Advisers's 13F filing for Q2 2022, filed 18 Jul 2022.